2011
DOI: 10.1007/s00270-011-0148-4
|View full text |Cite
|
Sign up to set email alerts
|

Venous Thoracic Outlet Compression and the Paget-Schroetter Syndrome: A Review and Recommendations for Management

Abstract: Paget Schroetter syndrome, or effort thrombosis of the axillosubclavian venous system, is distinct from other forms of upper limb deep vein thrombosis. It occurs in younger patients and often is secondary to competitive sport, music, or strenuous occupation. If untreated, there is a higher incidence of disabling venous hypertension than was previously appreciated. Anticoagulation alone or in combination with thrombolysis leads to a high rate of rethrombosis. We have established a multidisciplinary protocol ove… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
51
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 79 publications
(51 citation statements)
references
References 20 publications
0
51
0
Order By: Relevance
“…PAGET-SCHROETTER SYNDROME Background PSS (otherwise known as thoracic outlet syndrome and previously known as effort thrombosis) is an uncommon cause of DVT of the subclavian vein, most commonly seen as a consequence of chronic compression of the subclavian vein at the level of the thoracic outlet [4,5]. Primary axillary-subclavian vein thrombosis was first described by Paget in 1875 and Von Schroetter in 1884 and it was named the "Paget-Schroetter syndrome" by Hughes [6] in 1948.…”
mentioning
confidence: 99%
“…PAGET-SCHROETTER SYNDROME Background PSS (otherwise known as thoracic outlet syndrome and previously known as effort thrombosis) is an uncommon cause of DVT of the subclavian vein, most commonly seen as a consequence of chronic compression of the subclavian vein at the level of the thoracic outlet [4,5]. Primary axillary-subclavian vein thrombosis was first described by Paget in 1875 and Von Schroetter in 1884 and it was named the "Paget-Schroetter syndrome" by Hughes [6] in 1948.…”
mentioning
confidence: 99%
“…It can lead to chronic venous insufficiency, pain, edema, and hyperpigmentation [5]. Approximately 10 of patients with PSS develop pulmonary embolus [6].…”
Section: Discussionmentioning
confidence: 99%
“…In order to reduce the risk of post-thrombotic syndrome, definitive thrombotic therapy is often necessary utilizing both mechanical thrombectomy and pharmacologic thrombolysis [7]. Definitive surgical correction of the underlying anatomic abnormality is critical to prevent recurrence [4,6]. The timing of these procedures however remains controversial [3].…”
Section: Discussionmentioning
confidence: 99%
“…The objective of treatment is to prevent the recurrence of the thrombosis, which is associated with significant morbidity [21]. Treatment involves an early thrombolytic therapy (within 2 weeks) followed by an anticoagulation (1 -3 months) and delayed surgery [5,20]. Due to logistic reasons we were unable to provide thrombolysis in our institution.…”
Section: Discussionmentioning
confidence: 99%
“…The most common presentation of vTOS is an axillosubclavian vein thrombosis, which is also known as PagetSchroetter syndrome [3,6,20]. The objective of treatment is to prevent the recurrence of the thrombosis, which is associated with significant morbidity [21].…”
Section: Discussionmentioning
confidence: 99%